Apyx Medical (APYX) Inventory (2010 - 2026)

Apyx Medical (APYX) has reported Inventory for 17 consecutive years, with $11.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 27.93% year-over-year to $11.9 million; the trailing twelve-month figure through Jun 2026 stood at $11.9 million (up 27.93% YoY), and the FY2025 full-year result was $9.8 million, up 14.11% from the prior year.
• Inventory rose to $11.9 million in Q2 2026 per APYX's latest filing, from $10.6 million in the prior quarter.
• Across five years, Inventory topped out at $12.0 million in Q3 2022 and bottomed at $7.0 million in Q1 2022.
• Historically, Inventory has averaged $10.2 million across 5 years, with a median of $10.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Inventory surged 99.37% in 2022, then decreased 20.39% in 2024.
• Over 5 years, Inventory stood at $11.8 million in 2022, then declined by 8.47% to $10.8 million in 2023, then slipped by 20.39% to $8.6 million in 2024, then advanced by 14.11% to $9.8 million in 2025, then gained by 21.6% to $11.9 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $11.9 million, $10.6 million, and $9.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.